ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,024
Screening encounters
3,451
Diagnostic referrals
654
Outstanding pathways
243

Screening pathway

  1. Screening3,451Encounters
  2. Positive finding1,182Documented findings
  3. Referral654Diagnostic referrals
  4. Follow-up770Diagnostic visits
  5. Outcome411Resolved pathways

Stage totals use different units. Pending pathways: 243. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 2248 · EXP-2248Synthetic · Site B

Full participant history through 2026-06-25, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA technically uninterpretable · Inadequate
  3. · Repeat plan · VIA · Inadequate result · Scheduled for 2025-09-25
  4. · Screening · VIA · Repeat · Inadequate result
  5. · Screening result · VIA · VIA positive · Adequate
  6. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-05-23
  7. · Diagnostic referral · EXP-2248-T-R
  8. · Contact attempt · Unsuccessful
  9. · Diagnostic booking · Initial booking
  10. · Contact attempt · Reached
  11. · Diagnostic visit · Attended
  12. · Diagnosis · Colposcopy · Biopsy collected
  13. · Diagnosis · Histopathology · High-grade lesion
  14. · Follow-up disposition · Resolved · EXP-2248-T-R
  15. · Treatment · Synthetic precancer treatment
  16. · Surveillance plan · HPV DNA · After treatment · Scheduled for 2027-02-16
  17. · Screening · HPV DNA · Repeat · Prior VIA positive
  18. · Screening result · HPV DNA · HPV detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

3024 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-1317 · Expanded synthetic participant 1317Site C — Rural Outreach Programme
EXP-1318 · Expanded synthetic participant 1318Site A — Urban Referral Hub
EXP-1320 · Expanded synthetic participant 1320Site E — Resource-Constrained Navigation Programme
EXP-1323 · Expanded synthetic participant 1323Site A — Urban Referral Hub
EXP-1325 · Expanded synthetic participant 1325Site C — Rural Outreach Programme
EXP-1327 · Expanded synthetic participant 1327Site C — Rural Outreach Programme
EXP-1328 · Expanded synthetic participant 1328Site B — Peri-Urban Access Programme
EXP-1329 · Expanded synthetic participant 1329Site A — Urban Referral Hub
EXP-1330 · Expanded synthetic participant 1330Site E — Resource-Constrained Navigation Programme
EXP-1331 · Expanded synthetic participant 1331Site D — Community Engagement Programme
EXP-1332 · Expanded synthetic participant 1332Site B — Peri-Urban Access Programme
EXP-1333 · Expanded synthetic participant 1333Site A — Urban Referral Hub
EXP-1335 · Expanded synthetic participant 1335Site A — Urban Referral Hub
EXP-1336 · Expanded synthetic participant 1336Site B — Peri-Urban Access Programme
EXP-1337 · Expanded synthetic participant 1337Site D — Community Engagement Programme
EXP-1342 · Expanded synthetic participant 1342Site A — Urban Referral Hub
EXP-1343 · Expanded synthetic participant 1343Site D — Community Engagement Programme
EXP-1344 · Expanded synthetic participant 1344Site C — Rural Outreach Programme
EXP-1348 · Expanded synthetic participant 1348Site C — Rural Outreach Programme
EXP-1349 · Expanded synthetic participant 1349Site E — Resource-Constrained Navigation Programme
EXP-1350 · Expanded synthetic participant 1350Site A — Urban Referral Hub
EXP-1351 · Expanded synthetic participant 1351Site D — Community Engagement Programme
EXP-1352 · Expanded synthetic participant 1352Site C — Rural Outreach Programme
EXP-1354 · Expanded synthetic participant 1354Site D — Community Engagement Programme
EXP-1355 · Expanded synthetic participant 1355Site A — Urban Referral Hub

Programme insights

Encounters by modality

VIA
1384
HPV DNA
1565
Cytology
502

Navigation activity

Barrier documented
558
Contact attempt
964
Navigation intervention
241
Diagnostic booking
812
Diagnostic visit
770

Documented barriers

Contact difficulty
182
Transport difficulty
174
Appointment coordination
202

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.